WAYFIND-R: A global, real-world database of patients (pts) with a solid tumour profiled with next-generation sequencing (NGS)

被引：0
|
作者：
Blay, J-Y. [1 ]
Hackshaw, A. [2 ,3 ]
Le Tourneau, C. [4 ]
Geissler, J. [5 ]
Ferro, A. [6 ]
Schirgruber, E. [7 ]
Skatkova, O. [8 ]
Dienstmann, R. [9 ]
机构：
[1] Ctr Leon Berard, Dept Med, Lyon, France
[2] Canc Res UK, Clin Trials, London, England
[3] UCL, Canc Trials Ctr, London, England
[4] Inst Curie, Dept Drug Dev & Innovat D3i, Paris, France
[5] Patvocates GmbH, Patvocates Network, Riemerling Hohenbrunn, Germany
[6] Roche Prod Ltd, RWD Oncol, PD Data Sci, Welwyn Garden City, England
[7] F Hoffmann La Roche Ltd, Global Product Dev Med Affairs, Basel, Switzerland
[8] F Hoffmann La Roche AG Switzerland, Global Product Dev Med Affairs Operat, Basel, Switzerland
[9] Oncoclin Grp, Oncoclin Precis Med, Sao Paulo, Brazil
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2929
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
206P
引用
收藏
页码：S264 / S265
页数：2
相关论文
共 50 条
  • [31] Real-world data of off-label drug use in patients with actionable genomic alterations on next-generation sequencing
    Souza, Gabriel Roman
    Abdalla, Ahmed
    Arora, Sukeshi
    Mahadevan, Daruka
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (03) : 643 - 649
  • [32] MET Amplification in Non-Small Cell Lung Cancer (NSCLC)-A Consecutive Evaluation Using Next-Generation Sequencing (NGS) in a Real-World Setting
    Schubart, Christoph
    Stoehr, Robert
    Toegel, Lars
    Fuchs, Florian
    Sirbu, Horia
    Seitz, Gerhard
    Seggewiss-Bernhardt, Ruth
    Leistner, Rumo
    Sterlacci, William
    Vieth, Michael
    Seidl, Christoph
    Mugler, Michael
    Kapp, Markus
    Hohenforst-Schmidt, Wolfgang
    Hartmann, Arndt
    Haller, Florian
    Erber, Ramona
    CANCERS, 2021, 13 (19)
  • [33] Next-generation sequencing (NGS) of circulating cell-free DNA (cfDNA) in patients (pts) with advanced hepatocellular carcinoma (HCC).
    Erinjeri, Joseph Patrick
    Capanu, Marinela
    Do, Richard K. G.
    Solit, David B.
    Shah, Ronak H.
    Berger, Michael F.
    Abou-Alfa, Ghassan K.
    Harding, James J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [34] Commercial next generation sequencing in a real-world cohort of patients with metastatic breast cancer
    Taneja, Kamil
    Cohen, Jules A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [35] Distribution of receptor tyrosine kinase (RTK) nsSNPs in breast cancer (BC) patients (pts) using next-generation sequencing (NGS).
    Morris, Lindsay Kaye
    Stein, Matthew
    Karri, Saradasri
    Sareen, Srishti
    Patel, Kruti
    Vidal, Gregory A.
    Schwartzberg, Lee Steven
    Martin, Michael Gary
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [36] Real-World Experiences of Next-Generation Sequencing in Oncology: From an Indian Multicenter Registry and Collaborative Centers
    Philips, Ashwin Oommen
    Panda, Soumya Surath
    Cyriac, Sunu
    Moharana, Lalatendu
    Kilaru, Sindhu
    Kolluri, Spoorty
    Rathnam, Krishnakumar
    Saju, S. V.
    Raju, Honey Susan
    Kayal, Smita
    Biswajit, Dubashi
    Sehrawat, Amit
    Sundriyal, Deepak
    Jose, Anil T.
    Raju, Sreeja
    Paul, Preethi
    Ganesan, Prasanth
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2024,
  • [37] Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience
    Kim, Yoo-Na
    Chung, Yun Soo
    Lee, Ji Hyun
    Park, Eunhyang
    Lee, Seung-Tae
    Kim, Sunghoon
    Lee, Jung-Yun
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2023, 34 (06)
  • [38] Actionable mutational profiling in solid tumors using hybrid-capture-based next-generation sequencing in a real-world setting in Spain
    Zazo, Sandra
    Perez-Buira, Sandra
    Carvajal, Nerea
    Plaza-Sanchez, Jenifer
    Manso, Rebeca
    Perez-Gonzalez, Nuria
    Dominguez, Carolina
    Prieto-Potin, Ivan
    Rubio, Jaime
    Domine, Manuel
    Lozano, Virginia
    Mohedano, Patricia
    Carcedo, David
    Carias, Rafael
    Rojo, Federico
    CANCER MEDICINE, 2024, 13 (03):
  • [39] Molecular determinants of response and resistance to anti-PD-(L)1 blockade in patients with NSCLC profiled with targeted next-generation sequencing (NGS).
    Hellmann, Matthew David
    Sanchez-Vega, Francisco
    La, Konnor
    Rizvi, Hira
    Halpenny, Darragh
    Plodkowski, Andrew
    Long, Niamh
    Chatila, Walid
    Jonsson, Philip
    Arbour, Kathryn Cecilia
    Chaft, Jamie E.
    Rudin, Charles M.
    Kris, Mark G.
    Berger, Michael F.
    Taylor, Barry S.
    Zehir, Ahmet
    Arcila, Maria E.
    Ladanyi, Marc
    Riely, Gregory J.
    Schultz, Nikolaus
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [40] Disparities in the incidence of next-generation sequencing (NGS) among patients (pts) with advanced or metastatic prostate cancer (mPC) and urothelial carcinoma (mUC)
    Jo, Yeonjung
    Tripathi, Nishita
    Roy, Soumyajit
    Thomas, Vinay Mathew
    Fortuna, Gliceida Galarza
    Chehade, Chadi Hage
    Gebrael, Georges
    Narang, Arshit
    Campbell, Patrick
    Gupta, Sumati
    Maughan, Benjamin L.
    Agarwal, Neeraj
    Swami, Umang
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 542 - 542
12345